List view / Grid view
9 October 2014 | By kdm communications
Avacta’s Optim® 2 platform is an innovative analytical instrument designed to probe multiple protein stability indicating parameters at high speed using ultra-low sample volumes...
30 July 2014 | By kdm communications
Avacta Analytical has released a number of software updates for its innovative Optim® series of biophysical characterization instruments...
2 June 2014 | By kdm communications
Avacta Analytical is pleased to announce its sponsorship of this year’s Protein Formulation Development and Drug Delivery Forum in Barcelona, Spain...
7 May 2013 | By kdm communications limited
Scientists at the specialised biotech company PharmAbcine are completing formulation and stability studies in a fraction of the time...
3 April 2013 | By kdm communications limited
Pharmaceutical developers at Synthon have chosen an Optim 1000 high throughput, micro-volume protein analysis system...
27 March 2013 | By kdm communications limited
Avacta Analytical has recently undertaken preformulation studies for a new targeted secretion inhibitor (TSI)...
5 February 2013 | By kdm communications limited
Avacta Analytical has unveiled the Optim® 2 micro-volume protein analysis and characterisation instrument...
23 October 2012 | By kdm communications limited
Avacta Analytical’s Optim® 1000 is proving a valuable asset to scientists at the MVSC, University of Kansas, USA...
27 September 2012 | By kdm communications limited
Deal marks Avacta’s entry to the third largest Asia-Pacific biotech market...
14 November 2011 | By kdm communications limited
Avacta Analytical is partnering with University College London as an industrial sponsor...
